Viatris, Inc. (VTRS)
16.51
+0.03
(+0.18%)
USD |
NASDAQ |
May 18, 16:00
16.50
-0.01
(-0.06%)
After-Hours: 20:00
Viatris EPS Diluted (Quarterly) : 0.1501 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | 0.4688 |
| Theravance Biopharma, Inc. | -0.0962 |
| Eli Lilly & Co. | 8.255 |
| Merck & Co., Inc. | -1.715 |
| Bristol Myers Squibb Co. | 1.308 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 176.40M |
| Revenue (Quarterly) | 3.520B |
| Total Expenses (Quarterly) | 3.344B |
| Enterprise Value | 31.54B |
| Gross Profit Margin (Quarterly) | 39.23% |
| Profit Margin (Quarterly) | 5.01% |
| Earnings Yield | -1.57% |
| Operating Earnings Yield | 6.81% |
| Normalized Earnings Yield | 1.876 |